Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Adjuvant Therapy: Adding a probiotic with a treatment, not stopping any drug or any treatment for the patient.
Control Intervention1: Bioticas: Stains Contain :
Lactobacillus acidophill
Sponsors
Self
Eligibility
Inclusion criteria
Inclusion criteria: * Patients above 30 and below 65 years. * Patients diagnosed with Type 2 Diabetes Mellitus within 2years * HbA1C range between 6.5% - 9.0% (Moderate glycemic control) * hs - CRP with the range 1.0 10.0 mg/dL * No major changes in treatment for X 3 months. * Patients who agree to participate by knowing the objectives of the study and voluntarily participate
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improved Glycemic Control: A significant reduction in HbA1c, fasting blood glucose (FBG), Postbrandial blood gulcose, HOMA-IR levels in the probiotic group compared to the control group. Reduction in hsCRP Levels: A notable decrease in high-sensitivity C-reactive protein (hsCRP), indicating reduced systemic inflammation, which is linked to better glycemic controlTimepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: NIl | — |
Countries
India
Contacts
Public ContactDr S Arthanareeswaran
Vivekanandha Medical Care Hospital
Outcome results
None listed